rss
Evid Based Nurs 11:11 doi:10.1136/ebn.11.1.11
  • Treatment

Review: vaccines against human papillomavirus prevent cervical cancer precursors in young women

L Rambout

Correspondence to: Ms L Rambout, Ottawa Hospital, Ottawa, Ontario, Canada; lrambout@ottawahospital.on.ca

QUESTION

Do vaccines against human papillomavirus (HPV) prevent cervical cancer precursors in young women?

METHODS

Data sources:

Medline and EMBASE/Excerpta Medica (to May 2007); Medline in process (to June 2007); Cochrane Library and Cochrane Central Register of Controlled Trials (Issue 1, 2007); conference proceedings (2004–7); clinical trial registers; Google Scholar; public health announcements; reference lists; and vaccine manufacturers.

Study selection and assessment:

randomised controlled trials (RCTs) that compared a vaccine against ⩾1 oncogenic type of HPV with placebo or no HPV vaccine for prophylaxis of oncogenic HPV-related infection and disease in women. 9 reports of 6 RCTs (n = 40 323; mean age 20 y, range 15–26 y) met the selection criteria. 1 RCT (n = 2392) evaluated a monovalent HPV 16 vaccine, 2 RCTs …

No Related Web Pages

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article